BMC Integrated Care Services (BMCICS) promotes the highest quality of coordinated patient care, patient safety and cost effective care among its participating providers through our integrated and coordinated managed care contracts and related medical management programs.
Medicare Designates BMCICS as an Accountable Care Organization (ACO).
BMCICS provides information to physicians and their staff on our managed care contracts, their requirements and their implementation processes.
Our medical management program supports our providers in promoting high-quality, efficient care by:
- Minimizes variations in practice by monitoring, quality and effectiveness
- Monthly quality reports
- Provides prior authorizations for medically necessary or medically appropriate care
- Conducts provider and member surveys
- Credentials and re-credentials providers
ACO Name and Location
BMC Integrated Care Services, Inc. (BMCICS)
720 Harrison Ave.
Boston, MA 02118
ACO Primary Contact
Composition of ACO
A partnership between a hospital and ACO professionals, specifically:
- Boston Medical Center, an academic medical center located in Boston's South End
- Physicians who are members of the Boston University faculty and the Boston Medical Center medical staff
- Boston University Affiliated Physicians, a community physician group affiliated with Boston Medical Center
- Seven of the local Community Health Centers that work closely with Boston Medical Center
- Child Health Foundation of Boston, Inc.
- Codman Square Health Center
- South Boston Community Health Center, Inc.
- Boston University Mallory Pathology Associates, Inc.
- Faculty Practice Foundation Inc
- Internal Medical Associates-EBNHC
- Boston University Obstetrics and Gynecology Foundation, Inc.
- Boston University Eye Associates, Inc.
- Boston University Medical Center Otolaryngologic Foundation, Inc.
- Boston University Affiliated Physicians
- Boston University General Surgical Associates, Inc.
- Boston University Medical Center Radiologists, Inc.
- Boston Emergency Physician Foundation, Inc.
- Boston University Medical Center Urologists, Inc.
- Boston University Neurosurgical Associates, Inc.
- Boston Medical Center Corporation
- Boston University Dermatology, Inc.
- Boston University Family Medicine, Inc.
- Boston University Orthopaedic Surgical Associates, Inc.
- Boston University Psychiatry Associates
- Boston University Neurology Associates, Inc.
- Faculty Practice Foundation Boston Univ Plastic Surgery Assoc
- Dorchester House Multi-Service Center
- Faculty Practice Foundation Inc
- Upham's Corner Health Committee, Inc.
- South End Community Health Center
None of the above participants are involved in a joint venture between ACO professionals and hospital.
ACO Governing Body
- David L. Coleman, voting member, Faculty Practice Foundation Inc
- William Creevy, voting member, President of Faculty Practice Foundation
- Jonathan Olshaker, voting member, Boston Emergency Physician Foundation
- Aviva Lee-Parritz, voting member, Boston University Obstetrics and Gynecology Foundation
- Alexander Norbash, voting member, Boston University Medical Center Radiologists
- Robert Vinci, voting member, Child Health Foundation of Boston, Inc
- Frank Doyle, voting member, Executive Director of Healthnet
- Richard Silveria, voting member and Treasurer, Boston Medical Center Corporation
- Ravin Davidoff, voting member, Boston Medical Center Corporation
- Stanley Hochberg, voting member and President, BMCICS
- William Halpin, voting member, South Boston Community Health Center
- Brian Jack, voting member, Boston University Family Medicine
- Charles Tifft, voting member, Boston University Affiliated Physicians
- Larry Culpepper, voting member, Boston University Family Medicine
- Lisa Caruso, voting member, Faculty Practice Foundation Inc
- Jeffrey Samet, voting member, Faculty Practice Foundation Inc
- Charles Williams, voting member, Medical Director of Healthnet
- Julita Mir, voting member, Dorchester House Multi-Service Center
- Philip Severin, voting member, Codman Square Health Center
- Michael White, Non voting member, Boston University School of Medicine
- Aram Chobanian, voting member, Medicare Beneficiary Representative
Key Clinical and Administrative Leadership
- President: Stanley Hochberg, MD
- Treasurer: Richard Silveria
- Medical Director: Brian Jacobson, MD, MPH
ACO Committees and Committee Leadership
- Medical Management Committee, Stanley Hochberg, MD, Chair
- Executive Committee, Stanley Hochberg, MD, Chair
- Finance and Contracts Committee, William Creevy, MD, Chair
- Nominating Committee, Ravin Davidoff, MD, Chair
Amount of Shared Savings/Losses
- Agreement period beginning 2015, Performance Year 2015: $4,217,885
Shared Savings Distribution
- Agreement period beginning 2015, Performance Year 2015
- Proportion invested in infrastructure: 50%
- Proportion of distribution to ACO participants: 50%
Payment Rule Waivers
- No, our ACO does not utilize the SNF 3-Day Rule Waiver
Quality Performance Results
|2015 Reporting Period|
|Measure Number||Measure Name||ACO Performance Rate||Mean Performance Rate (SSP- ACOs)|
|ACO-1||CAHPS: Getting Timely Care, Appointments, and Information||76.01||80.61|
|ACO-2||CAHPS: How Well Your Providers Communicate||94.35||92.65|
|ACO-3||CAHPS: Patients’ Rating of Provider||93.73||91.94|
|ACO-4||CAHPS: Access to Specialists||78.10||83.61|
|ACO-5||CAHPS: Health Promotion and Education||64.66||59.06|
|ACO-6||CAHPS: Shared Decision Making||75.11||75.17|
|ACO-7||CAHPS: Health Status/Functional Status||69.92||72.30|
|ACO-34||CAHPS: Stewardship of Patient Resources*||22.41||26.87|
|ACO-8||Risk Standardized, All Condition Readmission||15.41||14.86|
|ACO-35||Skilled Nursing Facility 30-day All-Cause Readmission Measure (SNFRM)* Readmission||20.54||18.07|
|ACO-36||All-Cause Unplanned Admissions for Patients with Diabetes*||42.84||54.60|
|ACO-37||All-Cause Unplanned Admissions for Patients with Heart Failure*||73.38||76.96|
|ACO-38||All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions||57.22||62.92|
|ACO-9||Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)||1.08||1.11|
|ACO-10||Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)||1.16||1.04|
|ACO-11||Percent of Primary Care Physicians who Successfully Meet Meaningful Use Requirements||90.79%||76.22%|
|ACO-39||Documentation of Current Medications in the Medical Record*||77.61%||84.07%|
|ACO-13||Falls: Screening for Future Fall Risk||42.18%||56.46%|
|ACO-14||Preventive Care and Screening: Influenza Immunization||67.96%||62.03%|
|ACO-15||Pneumonia Vaccination Status for Older Adults||77.03%||63.73%|
|ACO-16||Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up||56.11%||71.15%|
|ACO-17||Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention||83.21%||90.16%|
|ACO-18||Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan||27.71%||45.25%|
|ACO-19||Colorectal Cancer Screening||64.94%||60.06%|
|ACO-20||Breast Cancer Screening||75.33%||65.67%|
|ACO-21||Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented||44.22%||70.04%|
|ACO-40||Depression Remission at Twelve Months*||N/A||N/A|
|ACO-27||Diabetes Mellitus: Hemoglobin A1c Poor Control||18.05%||20.38%|
|ACO-41||Diabetes: Eye Exam*||57.52%||41.05%|
|ACO-28||Hypertension: Controlling High Blood Pressure||60.88%||69.62%|
|ACO-30||Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic||89.90%||83.82%|
|ACO-31||Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)||94.92%||87.22%|
|ACO-33||Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)||87.50%||77.73%|
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.
* = Measure required beginning Reporting Year 2015.
N/A = Reporting on the depression remission measure is not required for 2015, as indicated by N/A.